Atlas Trials

Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.

Clinical trial NCT03616587 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03616587
Sponsor
AstraZeneca
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
ER+ HER2- Advanced Breast Cancer
Start date
2018-10-11
Primary completion
2024-09-16
Enrollment
396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.